| 1 |
Alakwaa_2020 |
Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data |
Alakwaa, Fadhl M. |
2020 |
2020-04-14 |
COMM-USE |
Y |
PMC7159901 |
32291351.0 |
10.1128/msystems.00297-20 |
j4u4fbba |
0.772260 |
|
|
| 2 |
Li_G_2020 |
A close-up on COVID-19 and cardiovascular diseases |
Li, Gang; Hu, Rui; Gu, Xuefang |
2020 |
2020-04-08 |
PMC |
Y |
|
|
10.1016/j.numecd.2020.04.001 |
13akn7dm |
0.690563 |
|
|
| 3 |
Liao_2020 |
The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing |
Minfeng Liao; Yang Liu; Jin Yuan; Yanling Wen; Gang Xu; Juanjuan Zhao; Lin Chen; Jinxiu Li; Xin Wang; Fuxiang Wang; Lei Liu; Shuye Zhang; Zheng Zhang |
2020 |
2020-02-26 |
BioRxiv |
Y |
|
|
10.1101/2020.02.23.20026690 |
8l1vfsbc |
0.614468 |
|
|
| 4 |
Riva_2020 |
A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals |
Laura Riva; Shuofeng Yuan; Xin Yin; Laura Martin-Sancho; Naoko Matsunaga; Sebastian Burgstaller-Muehlbacher; Lars Pache; Paul P. De Jesus; Mitchell V. Hull; Max Chang; Jasper Fuk-Woo Chan; Jianli Cao; Vincent Kwok-Man Poon; Kristina Herbert; Tu-Trinh Nguyen; Yuan Pu; Courtney Nguyen; Andrey Rubanov; Luis Martinez-Sobrido; Wen-Chun Liu; Lisa Miorin; Kris M. White; Jeffrey R. Johnson; Christopher Benner; Ren Sun; Peter G. Schultz; Andrew Su; Adolfo Garcia-Sastre; Arnab K. Chatterjee; Kwok-Yung Yuen; Sumit K. Chanda |
2020 |
2020-04-17 |
BioRxiv |
Y |
|
|
10.1101/2020.04.16.044016 |
1fgnfh62 |
0.609455 |
|
|
| 5 |
Yamamoto_2020 |
Nelfinavir inhibits replication of severe acute respiratory syndrome coronavirus 2 in vitro. |
Norio Yamamoto; Shutoku Matsuyama; Tyuji Hoshino; Naoki Yamamoto |
2020 |
2020-04-08 |
BioRxiv |
Y |
|
|
10.1101/2020.04.06.026476 |
662pfa61 |
0.570660 |
|
|
| 6 |
Li_M_2020 |
The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study |
Li, Mengmeng; Chen, Liang; Zhang, Jingxiao; Xiong, Chenglong; Li, Xiangjie |
2020 |
2020-04-16 |
COMM-USE |
Y |
PMC7161957 |
32298273.0 |
10.1371/journal.pone.0230295 |
yz9yhnbx |
0.530762 |
|
|
| 7 |
Li_J_2020 |
Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease |
Li, Jie; Fan, Jian-Gao |
2020 |
2020-03-30 |
NONCOMM |
Y |
PMC7132021 |
32274341.0 |
10.14218/jcth.2020.00019 |
v3qx51f8 |
0.520960 |
Bogoch_2020 |
|
| 8 |
Rosa_2020 |
Clinical trials on drug repositioning for COVID-19 treatment |
Rosa, Sandro G. Viveiros; Santos, Wilson C. |
2020 |
2020-03-20 |
COMM-USE |
Y |
PMC7105280 |
|
10.26633/rpsp.2020.40 |
vxqdfiel |
0.520804 |
|
|
| 9 |
Wu_D_2020 |
TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib |
Wu, Dandan; Yang, Xuexian O. |
2020 |
2020-03-11 |
PMC |
Y |
|
|
10.1016/j.jmii.2020.03.005 |
8eh90ber |
0.506239 |
|
|
| 10 |
Rana_2020 |
Therapeutic Application of Chloroquine in Clinical Trials for COVID-19 |
Divya RSJB Rana; Santosh Dulal |
2020 |
2020-03-27 |
BioRxiv |
Y |
|
|
10.1101/2020.03.22.20040964 |
jc9ugexn |
0.493798 |
|
Devaux_2020 |
| 11 |
Cao_P_2020 |
The important role of polysaccharides from a traditional Chinese medicine-Lung Cleansing and Detoxifying Decoction against the COVID-19 pandemic |
Cao, Peng; Wu, Sanlan; Wu, Tingting; Deng, Yahui; Zhang, Qilin; Wang, Kaiping; Zhang, Yu |
2020 |
2020-04-22 |
PMC |
Y |
|
|
10.1016/j.carbpol.2020.116346 |
1f8yhppi |
0.474870 |
|
|
| 12 |
Lei_L_2020 |
The phenotypic changes of γδ T cells in COVID-19 patients |
Lei Lei; Hongbo Qian; Xiaofeng Yang; Xiaobo Zhou; Xingzhe Zhang; Dan Zhang; Tongxin Dai; Rui Guo; Lin Shi; Yanbin Cheng; Baojun Zhang; Jinsong Hu Hu; Yaling Guo |
2020 |
2020-04-07 |
BioRxiv |
Y |
|
|
10.1101/2020.04.05.20046433 |
5ekdfers |
0.465708 |
|
|
| 13 |
Elfiky_2020 |
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study |
Elfiky, Abdo A. |
2020 |
2020-03-25 |
PMC |
Y |
|
|
10.1016/j.lfs.2020.117592 |
3pxc5wot |
0.457045 |
|
|
| 14 |
Rizzo_2020 |
COVID-19 in the heart and the lungs: could we “Notch” the inflammatory storm? |
Rizzo, Paola; Vieceli Dalla Sega, Francesco; Fortini, Francesca; Marracino, Luisa; Rapezzi, Claudio; Ferrari, Roberto |
2020 |
2020-04-09 |
PMC |
Y |
PMC7144545 |
32274570.0 |
10.1007/s00395-020-0791-5 |
m6eal7lu |
0.454587 |
|
|
| 15 |
Santesmasses_2020 |
COVID-19 is an emergent disease of aging |
Didac Santesmasses; José Pedro Castro; Aleksandr A Zenin; Anastasia V Shindyapina; Maxim V Gerashchenko; Bohan Zhang; Csaba Kerepesi; Sun Hee Yim; Peter O Fedichev; Vadim N Gladyshev |
2020 |
2020-04-15 |
BioRxiv |
Y |
|
|
10.1101/2020.04.15.20060095 |
uatnaro4 |
0.450710 |
|
|
| 16 |
Yang_2020 |
Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome |
Yang Yang; Chenguang Shen; Jinxiu Li; Jing Yuan; Minghui Yang; Fuxiang Wang; Guobao Li; Yanjie Li; Li Xing; Ling Peng; Jinli Wei; Mengli Cao; Haixia Zheng; Weibo Wu; Rongrong Zou; Delin Li; Zhixiang Xu; Haiyan Wang; Mingxia Zhang; Zheng Zhang; Lei Liu; Yingxia Liu |
2020 |
2020-03-06 |
BioRxiv |
Y |
|
|
10.1101/2020.03.02.20029975 |
c3dxfet9 |
0.448834 |
|
|
| 17 |
DU_H_2020 |
Traditional Chinese Medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP) |
DU, Hong-Zhi; HOU, Xiao-Ying; MIAO, Yu-Huan; HUANG, Bi-Sheng; LIU, Da-Hui |
2020 |
2020-03-31 |
PMC |
Y |
|
|
10.1016/s1875-5364(20)30022-4 |
161zm74f |
0.439758 |
|
|
| 18 |
Zhu_S_2020 |
Emerging Therapeutic Strategies for COVID-19 patients |
Zhu, Shudong; Guo, Xialing; Geary, Kyla; Zhang, Dianzheng |
2020 |
2020-03-12 |
COMM-USE |
Y |
PMC7093072 |
|
10.15190/d.2020.2 |
rl3801n6 |
0.426150 |
|
Rismanbaf_2020 |
| 19 |
Zhou_2020 |
Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus |
Yonggang Zhou; Binqing Fu; Xiaohu Zheng; Dongsheng Wang; Changcheng Zhao; Yingjie qi; Rui Sun; Zhigang Tian; Xiaoling Xu; Haiming Wei |
2020 |
2020-02-20 |
BioRxiv |
Y |
|
|
10.1101/2020.02.12.945576 |
anls8gri |
0.416715 |
|
|
| 20 |
Elfiky_2020 |
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 |
Elfiky, Abdo A. |
2020 |
2020-05-01 |
None |
Y |
PMC7089605 |
32119961.0 |
10.1016/j.lfs.2020.117477 |
d7n1zy0b |
0.414300 |
|
|
| 21 |
Pei_S_2020 |
Convalescent Plasma to Treat COVID-19: Chinese Strategy and Experiences |
Shiyao Pei; Xi Yuan; Zhimin Zhimin Zhang; Run Run Yao; Yubin Xie; Minxue Minxue Shen; Bijuan Bijuan Li; Xiang Chen; Mingzhu Yin |
2020 |
2020-04-11 |
BioRxiv |
Y |
|
|
10.1101/2020.04.07.20056440 |
i0vxixf3 |
0.410058 |
|
Teixeira_da_Silva_2020 |
| 22 |
Liao_2020 |
Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies |
Liao, Jiayu; Way, George; Madahar, Vipul |
2020 |
2020-03-31 |
PMC |
Y |
|
|
10.1016/j.medidd.2020.100037 |
vijzfbyj |
0.399356 |
|
Devaux_2020 |
| 23 |
Ma_Y_2020 |
2019 novel coronavirus disease in hemodialysis (HD) patients: Report from one HD center in Wuhan, China |
Yiqiong Ma; Bo Diao; Xifeng Lv; Jili Zhu; Wei Liang; Lei Liu; Wenduo Bu; Huiling Cheng; Sihao Zhang; Lianhua Yang; Ming Shi; Guohua Ding; Bo Shen; Huiming Wang |
2020 |
2020-02-25 |
BioRxiv |
Y |
|
|
10.1101/2020.02.24.20027201 |
b2znv6pa |
0.396673 |
|
|
| 24 |
Abbott_2020 |
Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza |
Timothy R. Abbott; Girija Dhamdhere; Yanxia Liu; Xueqiu Lin; Laine Goudy; Leiping Zeng; Augustine Chemparathy; Stephen Chmura; Nicholas S. Heaton; Robert Debs; Tara Pande; Drew Endy; Marie La Russa; David B. Lewis; Lei S. Qi |
2020 |
2020-03-14 |
BioRxiv |
Y |
|
|
10.1101/2020.03.13.991307 |
xieqswct |
0.386840 |
|
|
| 25 |
Dong_2020 |
Characterization of anti-viral immunity in recovered individuals infected by SARS-CoV-2 |
Chen Dong; Ling Ni; Fang Ye; Meng-Li Chen; Yu Feng; Yong-Qiang Deng; Hui Zhao; Peng Wei; Jiwan Ge; Xiaoli Li; Lin Sun; Pengzhi Wang; Peng Liang; Han Guo; Xinquan Wang; Cheng-Feng Qin; Fang Chen |
2020 |
2020-03-20 |
BioRxiv |
Y |
|
|
10.1101/2020.03.17.20036640 |
dptgg05n |
0.377851 |
|
|
| 26 |
Chau_2020 |
The Imperfect Cytokine Storm: Severe COVID-19 with ARDS in Patient on Durable LVAD Support |
Chau, Vinh Q.; Oliveros, Estefania; Mahmood, Kiran; Singhvi, Aditi; Lala, Anuradha; Moss, Noah; Gidwani, Umesh; Mancini, Donna M.; Pinney, Sean P.; Parikh, Aditya |
2020 |
2020-04-08 |
PMC |
Y |
|
|
10.1016/j.jaccas.2020.04.001 |
921orhjg |
0.337539 |
|
Wu_D_2020 |
| 27 |
Kumar_2020 |
A short review on antibody therapy for COVID-19 |
Kumar, Govindarajan Venkat; Jeyanthi, Venkadapathi; Ramakrishnan, Saminathan |
2020 |
2020-04-20 |
PMC |
Y |
|
|
10.1016/j.nmni.2020.100682 |
rqeultbq |
0.335729 |
|
|
| 28 |
Liu_F_2020 |
Highly ACE2 Expression in Pancreas May Cause Pancreas Damage After SARS-CoV-2 Infection |
Furong Liu; Xin Long; Wenbin Zou; Minghao Fang; Wenjuan Wu; Wei Li; Bixiang Zhang; Wanguang Zhang; Xiaoping Chen; Zhanguo Zhang |
2020 |
2020-03-03 |
BioRxiv |
Y |
|
|
10.1101/2020.02.28.20029181 |
6uaj8fb7 |
0.329290 |
|
|
| 29 |
Gao_L_2020 |
Prognostic value of NT-proBNP in patients with severe COVID-19 |
Lei Gao; Dan Jiang; Xuesong Wen; Xiaocheng Cheng; Min Sun; Bin He; Lin-na You; Peng Lei; Xiao-wei Tan; Shu Qin; Guoqiang Cai; Dongying Zhang |
2020 |
2020-03-10 |
BioRxiv |
Y |
|
|
10.1101/2020.03.07.20031575 |
xle4bx49 |
0.319845 |
|
Marchese-Ragona_2020 |
| 30 |
Devaux_2020 |
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
Devaux, Christian A.; Rolain, Jean-Marc; Colson, Philippe; Raoult, Didier |
2020 |
2020-03-12 |
PMC |
Y |
|
|
10.1016/j.ijantimicag.2020.105938 |
da61tfr9 |
0.319845 |
|
|
| 31 |
Cao_Y_2020 |
Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence |
Cao, Yu-chen; Deng, Qi-xin; Dai, Shi-xue |
2020 |
2020-04-02 |
PMC |
Y |
|
|
10.1016/j.tmaid.2020.101647 |
b518n9dx |
0.312001 |
|
Devaux_2020 |